Tuesday Aug 12
Orexigen Therapeutics Sees Unusually High Options Volume
Orexigen Therapeutics saw unusually large options trading on Tuesday. Traders bought 1,049 put options on the company, AnalystRatingsNetwork.com reports.
Orexigen Therapeutics, Inc. Reports Corporate And Financial Results...
This overall increase in operating expenses reflects an increase in raw materials, inventory, and manufacturing-related expenses and in stock based compensation expense.
Applied Clinical Trials
Orexigen Receives CHMP Day 180 List of Outstanding Issues
NB32 / bupropion SR) is an investigational drug candidate being evaluated for weight loss.
Orexigen Therapeutics Given "Neutral" Rating at Zacks
's stock had its "neutral" rating restated by Zacks in a research report issued on Wednesday.